Metformin use and the Risk of Gastrointestinal Malignancies in Diabetic Populations: A Meta-Analysis

Metformin use has been associated with a decreased risk of cancer and improvement in overall cancer survival rates. However, scant data available regarding metformin’s role in the risk of Gastrointestinal (GI) malignancies in patients with type II diabetes.